Log in to save to my catalogue

Treatment landscape of triple-negative breast cancer — expanded options, evolving needs

Treatment landscape of triple-negative breast cancer — expanded options, evolving needs

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2596015372

Treatment landscape of triple-negative breast cancer — expanded options, evolving needs

About this item

Full title

Treatment landscape of triple-negative breast cancer — expanded options, evolving needs

Publisher

London: Nature Publishing Group UK

Journal title

Nature reviews. Clinical oncology, 2022-02, Vol.19 (2), p.91-113

Language

English

Formats

Publication information

Publisher

London: Nature Publishing Group UK

More information

Scope and Contents

Contents

Tumour heterogeneity and a long-standing paucity of effective therapies other than chemotherapy have contributed to triple-negative breast cancer (TNBC) being the subtype with the least favourable outcomes. In the past few years, advances in omics technologies have shed light on the relevance of the TNBC microenvironment heterogeneity, unveiling a...

Alternative Titles

Full title

Treatment landscape of triple-negative breast cancer — expanded options, evolving needs

Authors, Artists and Contributors

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_miscellaneous_2596015372

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2596015372

Other Identifiers

ISSN

1759-4774

E-ISSN

1759-4782

DOI

10.1038/s41571-021-00565-2

How to access this item